In summary, our study delineates a clear tumor-suppressive pathway in glioma: FTO demethylates and destabilizes EREG mRNA, which limits EREG-mediated activation of the PI3K/Akt pathway. The gene discussed is FTO; the disease is central nervous system cancer.